HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | A219869 | HETERO LABS LTD UNIT V
No patent or exclusivity listings for this strength.
Hetero Labs Ltd added a new product record (NDA 219869, Supplement 002) for the generic combination of losartan potassium and hydrochlorothiazide.
New: New record
Hetero Labs Ltd received FDA approval for losartan potassium and hydrochlorothiazide combination tablet (NDA 219869, strength 001).
New: New record
Hetero Labs Ltd received FDA approval for a new ANDA (application 219869, supplement 003) for a generic combination product containing losartan potassium and hydrochlorothiazide.
New: New record